Detailed View
BMRN - BioMarin Pharmaceutical Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
10,735,017,984
Adj EBIT (TTM)
472,837,500
Enterprise Value
8,263,652,984
Last Price
55.54
Earnings Yield
5.72%
Return on Capital
6.39%
Capital
7,397,003,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 766,208,000 | 129,640,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 874,565,000 | -44,610,000 |
| 2025-09-30 | 10-Q | 2025 | 776,133,000 | -46,692,000 |
| 2025-06-30 | 10-Q | 2025 | 825,410,000 | 276,887,000 |
| 2025-03-31 | 10-Q | 2025 | 745,145,000 | 223,893,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 747,313,000 | 161,407,000 |
| 2024-09-30 | 10-Q | 2024 | 745,740,000 | 113,893,000 |
| 2024-06-30 | 10-Q | 2024 | 712,029,000 | 120,452,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.